Mechanistic insights into zearalenone-accelerated colorectal cancer in mice using integrative multi-omics approaches
Computational and Structural Biotechnology Journal · 9 authors, 7 centres
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This preclinical study used a colon cancer xenograft mouse model to investigate how the mycotoxin zearalenone (ZEA) promotes tumor growth. It found that ZEA exposure accelerated tumor development by altering the gut microbiota, serum metabolites, and activating specific cancer-related pathways.
Full summary
443 CHARS
Key results showed that ZEA exposure promoted tumor growth, which was associated with the upregulation of the BEST4/AKT/ERK1/2 signaling pathway, reduced serum amino acid levels, and altered gut microbiota composition, including decreased short-chain fatty acid-producing bacteria. The findings provide mechanistic insights into a potential environmental risk factor for CRC but require further validation in humanized models or human studies.